Citius Pharmaceuticals, Inc. Increase (Decrease) in Notes Receivables
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Notes Receivables of $1.08 million for the 6-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesReceivables · last filed 2026-05-15
- Citius Pharmaceuticals, Inc. increase (decrease) in notes receivables for the quarter ending 2026-03-31 was -$2.97M.
- Citius Pharmaceuticals, Inc. increase (decrease) in notes receivables for the quarter ending 2025-12-31 was $4.05M.
| Period end | Increase (Decrease) in Notes Receivables 3 month | Increase (Decrease) in Notes Receivables 6 month |
|---|---|---|
| 2026-03-31 | -$2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $1.08M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.05M 10-Q · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |